Concepedia

Author

Barry S. Berman

Cancer Institute of Florida

Also Known As

B. S. Berman, Barry Berman, Barry S. Berman

15

Publications

1.9K

Citations

9

H-Index

15

Concepts

All Affiliations

Cancer Institute of FloridaMary Crowley Cancer Research CenterThe University of Texas MD Anderson Cancer CenterTexas Oncology
BS

About

Barry S. Berman is an author at Cancer Institute of Florida specializing in oncology, radiation oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

251

2

Health Sciences

1

1

156

3

Pharmacology

1

1

95

4

Surgical Oncology

1

1

156

5

Cancer Therapeutics

1

1

95

Barry S. Berman

×

6

Publications

700

Citations

6

H-Index

YearCitations

Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study

Patricia Mucci‐LoRusso, Barry S. Berman, Peter T. Silberstein,

European Journal of Pain

1998

175

Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update

Joseph L. Chin, R. Bryan Rumble, Marisa Kollmeier,

Journal of Clinical Oncology

2017

166

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update

Sandra L. Wong, Mark B. Faries, Erin B. Kennedy,

Annals of Surgical Oncology

2017

156

Phase 1 study of escalating-dose OncoGel® (ReGel®/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions

Svetislava J. Vukelja, Stephen P. Anthony, James C. Arseneau,

Anti-Cancer Drugs

2007

95

Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small-Cell Lung Cancer

John Nemunaitis, Thomas P. Meyers, Neil Senzer,

Molecular Therapy

2006

69

Irofulven Demonstrates Clinical Activity Against Metastatic Hormone-Refractory Prostate Cancer in a Phase 2 Single-Agent Trial

Neil Senzer, James C. Arsenau, Donald Richards,

American Journal of Clinical Oncology

2005

39

Page 1